Biomarin Pharmaceutical reported $501.69M in Sales Revenues for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acadia Pharmaceuticals ACAD:US $ 115.22M 8.67M
Acceleron Pharma XLRN:US $ 27.94M 3.18M
Acorda Therapeutics ACOR:US $ 31.78M 2.92M
Alexion Pharmaceuticals ALXN:US $ 1636.5M 44.7M
Alnylam Pharmaceuticals ALNY:US $ 220.55M 42.99M
Amgen AMGN:US $ 6526M 625M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Bayer BAYN:GR € 10854M 1474M
Biogen BIIB:US $ 2778.9M 3.9M
Biomarin Pharmaceutical BMRN:US $ 501.69M 15.66M
Bluebird Bio BLUE:US $ 7.47M 5.32M
Gilead Sciences GILD:US $ 6217M 206M
Gw Pharmaceuticals GWPH:US $ 152.47M 4.24M
Insmed INSM:US $ 45.37M 5.15M
Intercept Pharmaceuticals ICPT:US $ 96.58M 14.92M
IONIS PHARMACEUT IONS:US $ 125.75M 14.14M
Moderna Inc MRNA:US 4.35B 2.42B
Neurocrine Biosciences NBIX:US $ 288.9M 52.3M
Ptc Therapeutics PTCT:US $ 116.68M 1.27M
Puma Biotechnology PBYI:US $ 53.38M 44.78M
Regeneron Pharmaceuticals REGN:US $ 5138.5M 2609.8M
Sangamo Biosciences SGMO:US $ 27.87M 1.59M
Sarepta Therapeutics SRPT:US $ 164.09M 17.16M
Seattle Genetics SGEN:US $ 388.48M 56.5M
Ultragenyx Pharmaceutical RARE:US $ 86.98M 12.42M
United Therapeutics UTHR:US $ 446.5M 67.4M
Vertex Pharmaceuticals VRTX:US $ 1793.37M 69.06M
YTE INCY:US $ 705.71M 100.99M